Skip to contentClarengateINTELLIGENCE
Coverage & freshness About Clarengate
Companies/07636591

Nanogenics Limited

Research and experimental development on biotechnology · London

ActiveUnited KingdomIncorporated 2011Private Limited Company
Register Ask analyst

Ownership evidence

Reported ownership and control rights in this business, with source dates.

Reported ownership & control

1 without an end date · 3 ceased
Thalia Therapeutics PlcCorporate
Shares: over 50%, up to 75%Voting rights: over 50%, up to 75%

Notified 2023-10-05 · No cessation recorded

Source record 136971659
Show 3 ceased records
Ryboquin Company LtdCorporate
Shares: over 50%, up to 75%Voting rights: over 50%, up to 75%Right to appoint or remove directors

Notified 2018-05-11 · Ceased 2023-10-05

Source record 148239138
Applisci LtdCorporate
Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%

Notified 2016-06-30 · Ceased 2018-05-11

Source record 135867249
SH
Prof Stephen Lewis HartIndividual
Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%

Notified 2016-04-06 · Ceased 2018-05-11

Source record 135867080

People behind the business

Current appointments and the wider business interests of each person.

Appointments

2 current · 6 historical
LC
Luke CairnsCurrent director
Appointed 2023-10-05 · 3 yrs · Company Director
+4 others
PM
Paul MurrayCurrent director
Appointed 2021-08-10 · 5 yrs · Company Director
Show 6 historical appointments
NT
Nigel TheobaldResigned director
Resigned 2023-10-05 · 2 yrs · Company Director
JL
Jonathan LaneResigned director
Resigned 2020-09-18 · 3 yrs · Company Director
SN
Simon NewmanResigned director
Resigned 2018-05-11 · 6 yrs · Company Director
AW
Alan WalkerResigned director
Resigned 2018-05-11 · 3 yrs · Company Director
IM
Ian McdonaldResigned director
Resigned 2018-05-11 · 2 yrs · Company Director

Board profile

People with appointments
2
Directors assessed
2
Median age
55
Under 35
0
65 and over
0
Disqualified match
None active